ClinicalTrials.Veeva

Menu

Recurrent Atrial Fibrillation (Recurrent AF)

University of Cincinnati logo

University of Cincinnati

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: SEEQ monitor

Study type

Interventional

Funder types

Other

Identifiers

NCT02898545
2015-2478

Details and patient eligibility

About

This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.

Full description

Eligible individuals with no previous history of atrial fibrillation or flutter who develop a limited episode of atrial fibrillation during a hospital stay for an acute medical illness or non-cardiothoracic surgery or procedure. Patients will be monitored for a period of 1 month using Medtronic SEEQ monitors for recurrence. Subjects will self assign to wear the SEEQ monitor or standard of care. Individuals with implanted cardiac devices capable of detecting atrial fibrillation will also be included.

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Development of atrial fibrillation or flutter during a hospital stay following a non-cardiac procedure or acute medical illness
  • CHADS2VASc score of 2 or more

Exclusion criteria

  • Prior history of atrial fibrillation of flutter
  • Requiring ventilator support or in shock
  • Acute decompensated heart failure or EF =/< 40%
  • Greater than mild valvular heart disease
  • Other structural heart disease such as more than mild LVH, constrictive or restrictive cardiomyopathy
  • Hyperthyroidism uncontrolled at the time of diagnosis if known
  • Pulmonary embolism that requires thrombolysis or resulted in shock
  • Use of antiarrhythmic drugs (class I or III) at the time of discharge
  • Cardiothoracic surgery in the last 6 months

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1 participants in 2 patient groups

SEEQ monitor
Other group
Description:
Subjects will be monitored via use of the SEEQ monitor
Treatment:
Device: SEEQ monitor
Standard of care
No Intervention group
Description:
Subjects will not wear the SEEQ monitor or may have a pre-existing implanted device capable of detecting atrial fibrillation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems